Quick Answer
Nu-Med Plus, Inc. reported Cash and Equivalents of $2.4 thousand for fiscal year 2024.
Nu-Med Plus, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $2.4K | -65.1% |
| 2023 | $6.8K | -96.4% |
| 2020 | $188.5K | +2562.9% |
| 2019 | $7.1K | -95.8% |
| 2018 | $167.5K | -52.3% |
| 2017 | $351.0K | +2719.6% |
| 2016 | $12.4K | -59.7% |
| 2015 | $30.9K | -45.1% |
| 2014 | $56.3K | +325.4% |
| 2013 | $13.2K | +1709.7% |
| 2012 | $731.00 | -16.0% |
| 2011 | $870.00 | — |
| 2011 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $31.8K | +1.1% | -56.3% |
| June 30, 2021 | $72.8K | +1092.8% | -47.7% |
| March 31, 2021 | $139.3K | +659.8% | -26.1% |
| December 31, 2020 | $188.5K | +2562.9% | +498.5% |
| September 30, 2020 | $31.5K | -24.7% | +415.9% |
| June 30, 2020 | $6.1K | -61.1% | -66.7% |
| March 31, 2020 | $18.3K | -21.3% | +158.9% |
| December 31, 2019 | $7.1K | -95.8% | -83.1% |
- Nu-Med Plus, Inc. showed a decrease of -65.1% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from Nu-Med Plus, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: